Albers Jeffrey W.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
62
Insider Sells Sum
$78.46M

Insider Activity of Albers Jeffrey W.

According to the SEC Form 4 filings, Albers Jeffrey W., being in a position of

  1. director at Blueprint Medicines Corporation,
    оver the last 12 months, has bought 0 shares, and sold 100808 shares for $8.78M,
    over all time since 2015-11-02, has bought 0 shares, and sold 1165128 shares for $77.46M.

The largest sale of all time was on 2017-11-06 and amounted to 60000 shares of Blueprint Medicines Corporation for $4.22M.

Biography of Albers Jeffrey W.

No biography is available at this moment.

2024-12-19SaleBlueprint Medicines Corporation
BPMC
director
15,000
0.0237%
$89.77$1.35M+0.55%
2024-11-07SaleBlueprint Medicines Corporation
BPMC
director
5,000
0.0079%
$102.00$510,000-6.06%
2024-11-06SaleSpyre Therapeutics, Inc.
SYRE
director
6,700
0.0148%
$36.76$246,313-26.43%
2024-10-25SaleSpyre Therapeutics, Inc.
SYRE
director
300
0.0007%
$36.43$10,929-20.08%
2024-09-09SaleBlueprint Medicines Corporation
BPMC
director
19,702
0.0308%
$85.57$1.69M+5.07%
2024-08-26SaleKymera Therapeutics, Inc.
KYMR
director
5,000
0.0077%
$49.10$245,509-6.8%
2024-03-20SaleBlueprint Medicines Corporation
BPMC
director
25,073
0.0405%
$87.28$2.19M+6.58%
2024-03-07SaleBlueprint Medicines Corporation
BPMC
director
11,033
0.0178%
$90.69$1M+1.64%
2024-02-21SaleKymera Therapeutics, Inc.
KYMR
director
4,385
0.0075%
$39.05$171,227+9.15%
2024-02-20SaleKymera Therapeutics, Inc.
KYMR
director
615
0.0011%
$39.07$24,031+10.94%
2024-01-25SaleBlueprint Medicines Corporation
BPMC
director
25,000
0.0414%
$81.91$2.05M+13.46%
2024-01-23SaleKymera Therapeutics, Inc.
KYMR
director
10,000
0.0163%
$30.05$300,470+33.94%
2023-12-11SaleBlueprint Medicines Corporation
BPMC
director
5,000
0.008%
$79.07$395,350+13.54%
2023-11-30SaleBlueprint Medicines Corporation
BPMC
director
5,000
0.0083%
$70.55$352,750+31.42%
2023-11-24SaleBlueprint Medicines Corporation
BPMC
director
15,000
0.0243%
$67.51$1.01M+32.59%
2023-11-03SaleBlueprint Medicines Corporation
BPMC
director
1,485
0.0025%
$60.13$89,293+50.68%
2023-11-02SaleBlueprint Medicines Corporation
BPMC
director
4,634
0.0077%
$60.37$279,749+51.57%
2023-11-01SaleBlueprint Medicines Corporation
BPMC
director
3,881
0.0064%
$60.02$232,938+50.25%
2023-09-28SaleBlueprint Medicines Corporation
BPMC
director
6,898
0.0112%
$50.17$346,073+75.19%
2023-09-27SaleBlueprint Medicines Corporation
BPMC
director
18,102
0.0296%
$49.61$897,957+79.05%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.